Pharma
Define Ventures surveyed more than 40 executives from 15 of the top 20 pharma companies on the readiness of AI in healthcare, says Carolyn Magill, venture partner at the VC firm. A vast majority said AI is a priority in healthcare.
In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.
The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications.
Amino Health's navigation platform will provide health plans, third-party administrators, government agencies and health systems with tools to manage pharmacy and medical benefits.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
HIMSS25
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.
It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.
HIMSS25
Michele Krajewski, HIMSS' Global Health Conference Education Committee chair, explains how the committee ensures each year's conference curriculum reflects the interests and needs of HIMSS' diverse membership.
Americans with a prescription will have access to Novo Nordisk's obesity drug Wegovy through the Hims & Hers platform for $599 monthly.